G'day Optimosceptic. The ONLY two worthwhile things that are in progress are "sensitive" and "material" viz. funding for ATP855 and j/v reATP594. So, they can't give a running commentary and have just cut and pasted.
I'm awaiting a reply to an email and be happy to share it if there's anything worthwhile. IMO, they simply cannot continue at this rate of expenditure with no progress re both those "material" issues. I'm a very bad judge if there is "nothing" happening!!!
- Forums
- ASX - By Stock
- ICN
- Ann: Quarterly Activities Report - amended
Ann: Quarterly Activities Report - amended, page-4
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ICN (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.608M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ICN (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online